The Middle Market Review Insights on the Middle Market.

Subscribe Subscribe

Subscribe Today

Please provide valid email address

I want to receive:

Thanks for subscribing!

CEOs

CEO Weekly Outlook

Tags

Good afternoon, all. Today, we’re reading about 3 things that make mid-market CEOs different than large company CEOs. From the executive director of the National Center for the Middle Market, the discussion focuses on conservative growth projections, cash outlays, and frustration with talent shortage.

Meanwhile, Harvard Business Review tells us what executives can learn from venture capitalists regarding what drives returns. The advice includes spending enough time on company initiatives, rewarding tough questions, and forecasting far enough into the future.

Business Insights

Transaction Toolbox

Middle Market Move of the Week:

Consolidation continues in the healthcare markets. Private equity firm GTRC announced that its portfolio company Cord Blood Registry is being acquired by AMAG Pharmaceuticals, Inc. for $700 million.

Cord Blood Registry, the world’s largest newborn stem cell company, partnered with GTCR to improve market position, commercial infrastructure and growth prospects. In its acquisition by AMAG Pharmaceuticals, the company looks to continue advancing medical treatments for patients and their families. Read the full press release here.

Learn More About Joining Axial

Request Information

Subscribe to Middle Market Review

Subscribe to Middle Market Review

Please provide valid email address

I want to receive:

Subscribe

Thanks for subscribing!